Additionally, C-1311 effectively decreased tumor angiogenesis by downregulating the hypoxia-inducible factor-1 α (HIF-1α)/vascular endothelial growth factor (VEGF) pathway [21] and blocked quinone oxidoreductase 2 (NQO2) [22]. This evidence concerns the gene VEGFA and neoplasm.